Sex differences in angiotensin II- and aldosterone-induced hypertension: The central protective effects of estrogen

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 305, Issue 5, 2013, Pages

  Xue, Baojian ^a   Johnson, Alan Kim ^a,b   Hay, Meredith ^c,d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Blood pressure; Central nervous system; Estrogen estrogen receptor; Renin angiotensin aldosterone system; Sex difference

Indexed keywords

ALDOSTERONE; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

AMBIGUUS NUCLEUS; AREA POSTREMA; BLOOD PRESSURE REGULATION; BRAIN NUCLEUS; CALCIUM CELL LEVEL; CALCIUM CURRENT; CATECHOLAMINE NERVE CELL; ESTROGEN ACTIVITY; FACILITATION; FOREBRAIN; HEART PROTECTION; HYPERTENSION; HYPOTHALAMUS; NONHUMAN; ORGANUM VASCULOSUM OF THE LAMINA TERMINALIS; PARABRACHIAL NUCLEUS; PARASYMPATHETIC TONE; PARAVENTRICULAR THALAMIC NUCLEUS; POTASSIUM CURRENT; PREOPTIC NUCLEUS; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEX DIFFERENCE; SUBFORNICAL ORGAN;

BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM; ESTROGEN/ESTROGEN RECEPTOR; RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM; SEX DIFFERENCE;

ALDOSTERONE; ANGIOTENSIN II; ANIMALS; BRAIN; ESTROGENS; HUMANS; HYPERTENSION; MODELS, BIOLOGICAL; RENIN-ANGIOTENSIN SYSTEM; SEX FACTORS;

EID: 84883322145     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00222.2013     Document Type: Review

References (53)

1. Arias-Loza PA, Hu K, Dienesch C, Mehlich AM, König S, Jazbutyte V, Neyses L, Hegele-Hartung C, Heinrich Fritzemeier K, Pelzer T. Both estrogen receptor subtypes, alpha and beta, attenuate cardiovascular remodeling in aldosterone salt-treated rats. Hypertension 50: 432-438, 2007.
2. Bhatia K, Zimmerman MA, Sullivan JC. Sex differences in angiotensin-converting enzyme modulation of Ang (1-7) levels in normotensive WKY rats. Am J Hypertens 26: 591-598, 2013.
3. Brosnihan KB, Hodgin JB, Smithies O, Maeda N, Gallagher P. Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-alpha knock-out mice. Exp Physiol 93: 658-664, 2008.
4. Brown RD, Hilliard LM, Head GA, Jones ES, Widdop RE, Denton KM. Sex differences in the pressor and tubuloglomerular feedback response to angiotensin II. Hypertension 59: 129-135, 2012.
5. Cherney A, Edgell H, Krukoff TL. NO mediates effects of estrogen on central regulation of blood pressure in restrained, ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 285: R842-R849, 2003.
6. Crowley SD, Coffman TM. Recent advances involving the renin-angiotensin system. Exp Cell Res 318: 1049-1056, 2012.
7. Feng Y, Xia H, Cai Y, Halabi CM, Becker LK, Santos RA, Speth RC, Sigmund CD, Lazartigues E. Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circ Res 106: 373-382, 2010.
8. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53: 672-677, 2002.
9. Gingerich S, Krukoff TL. Estrogen in the paraventricular nucleus attenuates L-glutamate-induced increases in mean arterial pressure through estrogen receptor beta and NO. Hypertension 48: 1130-1136, 2006.
10. Guimaraes PS, Santiago NM, Xavier CH, Velloso EP, Fontes MA, Santos RA, Campagnole-Santos MJ. Chronic infusion of angiotensin-(1-7) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats. Am J Physiol Heart Circ Physiol 303: H393-H400, 2012.
11. Gupte M, Thatcher SE, Boustany-Kari CM, Shoemaker R, Yiannikouris F, Zhang X, Karounos M, Cassis LA. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arterioscler Thromb Vasc Biol 32: 1392-1399, 2012.
12. Ito K, Hirooka Y, Kimura Y, Sagara Y, Sunagawa K. Ovariectomy augments hypertension through rho-kinase activation in the brain stem in female spontaneously hypertensive rats. Hypertension 48: 651-657, 2006.
13. Jonklaas J, Buggy J. Angiotensin-estrogen central interaction: localization and mechanism. Brain Res 326: 239-249, 1985.
14. Jonklaas J, Buggy J. Angiotensin-estrogen interaction in female brain reduces drinking and pressor responses. Am J Physiol Regul Integr Comp Physiol 247: R167-R172, 1984.
15. Lachowicz A, Rebas E. Gender differences in steroid modulation of angiotensin II-induced protein kinase C activity in anterior pituitary of the rat. Biochem Biophys Res Commun 294: 95-100, 2002.
16. Laflamme N, Nappi RE, Drolet G, Labrie C, Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERα and ERβ) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J Neurobiol 36: 357-378, 1998.
17. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 144: 2179-2183, 2003.
18. Li Z, Hay M. 17-β-estradiol modulation of area postrema potassium currents. J Neurophysiol 84: 1385-1391, 2000.
19. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, Mc-Allen RM, Oldfield BJ, Mendelsohn FA, Chai SY. The brain reninangiotensin system: location and physiological roles. Int J Biochem Cell Biol 35: 901-918, 2003.
20. Milner TA, Drake CT, Lessard A, Waters EM, Torres-Reveron A, Graustein B, Mitterling K, Frys K, Iadecola C. Angiotensin II-induced hypertension differentially affects estrogen and progestin receptors in central autonomic regulatory areas of female rats. Exp Neurol 212: 393-406, 2008.
21. Pamidimukkala J, Hay M. 17β-estradiol inhibits angiotensin II activation of area postrema neurons. Am J Physiol Heart Circ Physiol 285: H1515-H1520, 2003.
22. Pamidimukkala J, Xue B, Newton LG, Lubahn DB, Hay M. Estrogen receptor-alpha mediates estrogen facilitation of baroreflex heart rate responses in conscious mice. Am J Physiol Heart Circ Physiol 288: H1063-H1070, 2005.
23. Pelzer T, Jazbutyte V, Hu K, Segerer S, Nahrendorf M, Nordbeck P, Bonz AW, Muck J, Fritzemeier KH, Hegele-Hartung C, Ertl G, Neyses L. The estrogen receptor-alpha agonist 16α-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovasc Res 67: 604-612, 2005.
24. Saleh MC, Connell BJ, Saleh TM. Autonomic and cardiovascular reflex responses to central estrogen injection in ovariectomized female rats. Brain Res 879: 105-114, 2000.
25. Saleh MC, Connell BJ, Saleh TM. Medullary and intrathecal injections of 17β-estradiol in male rats. Brain Res 867: 200-209, 2000.
26. Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ 3: 7, 2012.
27. Shenoy V, Grobe JL, Qi Y, Ferreira AJ, Fraga-Silva RA, Collamat G, Bruce E, Katovich MJ. 17β-Estradiol modulates local cardiac reninangiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats. Peptides 30: 2309-2315, 2009.
28. Shih CD. Activation of estrogen receptor β-dependent nitric oxide signaling mediates the hypotensive effects of estrogen in the rostral ventrolateral medulla of anesthetized rats. J Biomed Sci 16: 60, 2009.
29. Spary EJ, Maqbool A, Batten TF. Oestrogen receptors in the central nervous system and evidence for their role in the control of cardiovascular function. J Chem Neuroanat 38: 185-196, 2009.
30. Sullivan JC, Bhatia K, Yamamoto T, Elmarakby AA. Angiotensin (1-7) receptor antagonism equalizes angiotensin II-induced hypertension in male and female spontaneously hypertensive rats. Hypertension 56: 658-666, 2010.
31. Sullivan JC. Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. Am J Physiol Regul Integr Comp Physiol 294: R1220-R1226, 2008.
32. Tremblay AM, Dufour CR, Ghahremani M, Reudelhuber TL, Giguère V. Physiological genomics identifies estrogen-related receptor alpha as a regulator of renal sodium and potassium homeostasis and the renin-angiotensin pathway. Mol Endocrinol 24: 22-32, 2010.
33. Vongpatanasin W. Autonomic regulation of blood pressure in menopause. Semin Reprod Med 27: 338-345, 2009.
34. Wang G, Drake CT, Rozenblit M, Zhou P, Alves SE, Herrick SP, Hayashi S, Warrier S, Iadecola C, Milner TA. Evidence that estrogen directly and indirectly modulates C1 adrenergic bulbospinal neurons in the rostral ventrolateral medulla. Brain Res 1094: 163-178, 2006.
35. Wang G, Milner TA, Speth RC, Gore AC, Wu D, Iadecola C, Pierce JP. Sex differences in angiotensin signaling in bulbospinal neurons in the rat rostral ventrolateral medulla. Am J Physiol Regul Integr Comp Physiol 295: R1149-R1157, 2008.
36. Wei SG, Yu Y, Zhang ZH, Felder RB. Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol 296: H1425-H1433, 2009.
37. Wu KL, Chen CH, Shih CD. Nontranscriptional activation of PI3K/Akt signaling mediates hypotensive effect following activation of estrogen receptor β in the rostral ventrolateral medulla of rats. J Biomed Sci 19: 76, 2012.
38. Xu P, Sriramula S, Lazartigues E. ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. Am J Physiol Regul Integr Comp Physiol 300: R804-R817, 2011.
39. Xue B, Badaue-Passos D Jr, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Sex differences and central protective effect of 17β-estradiol in the development of aldosterone/NaCl-induced hypertension. Am J Physiol Heart Circ Physiol 296: H1577-H1585, 2009.
40. Xue B, Beltz TG, Johnson RF, Guo F, Hay M, Johnson AK. PVN adenovirus-siRNA injections silencing either NOX2 or NOX4 attenuate aldosterone/NaCl-induced hypertension in mice. Am J Physiol Heart Circ Physiol 302: H733-H741, 2012.
41. Xue B, Beltz TG, Yu Y, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Central interactions of aldosterone and angiotensin II in aldosteroneand angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 300: H555-H564, 2011.
42. Xue B, Pamidimukkala J, Lubahn DB, Hay M. Estrogen receptor-α mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am J Physiol Heart Circ Physiol 292: H1770-H1776, 2007.
43. Xue B, Singh M, Guo F, Hay M, Johnson AK. Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide. Am J Physiol Heart Circ Physiol 297: H1638-H1646, 2009.
44. Xue B, Zhang Z, Beltz TG, Johnson RF, Guo F, Hay M, Johnson AK. Estrogen receptor-beta (ERβ) in the PVN and RVLM plays an essential protective role in aldosterone/salt-induced hypertension in female rats. Hypertension 61: 1255-1262, 2013.
45. Xue B, Zhang Z, Guo F, Hay M, Johnson AK. Central blockade of angiotensin(1-7) or angiotensin II receptor type 2 (AT2) enhances aldosterone/ salt-induced increases in blood pressure in female rats. The Physiologist 54: 14, 2011.
46. Xue B, Zhang Z, Johnson RF, Johnson AK. Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment. Hypertension 59: 459-466, 2012.
47. Xue B, Zhang Z, Roncari CF, Guo F, Johnson AK. Aldosterone acting through the central nervous system sensitizes angiotensin II-induced hypertension. Hypertension 60: 1023-1030, 2012.
48. Xue B, Zhao Y, Johnson AK, Hay M. Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species. Am J Physiol Heart Circ Physiol 295: H1025-H1032, 2008.
49. Yang XP, Reckelhoff JF. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens 20: 133-138, 2011.
50. Yu Y, Xue BJ, Zhang ZH, Wei SG, Beltz TG, Guo F, Johnson AK, Felder RB. Early interference with p44/42 mitogen-activated protein kinase signaling in hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension. Hypertension 61: 842-849, 2013.
51. Zhang ZH, Yu Y, Kang YM, Wei SG, Felder RB. Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. Am J Physiol Heart Circ Physiol 294: H1067-H1074, 2008.
52. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295: 505-508, 2002.
53. Zimmerman MC, Sharma RV, Davisson RL. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 45: 717-723, 2005.